1
|
Fernández-Carrión MJ, Robles Campos R,
López Conesa A, Brusadín R and Parrilla Paricio P: Intrahepatic
multicystic biliary hamartoma: Presentation of a case report. Cir
Esp. 93:e103–e105. 2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Yoh T, Okamura R, Nakayama H, Lin X,
Nakamura Y and Kato T: Multicystic biliary hamartoma mimicking
intrahepatic cholangiocarcinoma: Report of a case. Clin J
Gastroenterol. 7:418–421. 2014.PubMed/NCBI View Article : Google Scholar
|
3
|
Min JK, Kim JM, Li S, Lee JW, Yoon H, Ryu
CJ, Jeon SH, Lee JH, Kim JY, Yoon HK, et al: L1 cell adhesion
molecule is a novel therapeutic target in intrahepatic
cholangiocarcinoma. Clin Cancer Res. 16:3571–3580. 2010.PubMed/NCBI View Article : Google Scholar
|
4
|
Karahan OI, Kahriman G, Soyuer I and Ok E:
Hepatic von Meyenburg complex simulating biliary
cystadenocarcinoma. Clin Imaging. 31:50–53. 2007.PubMed/NCBI View Article : Google Scholar
|
5
|
Sahani DV, Kadavigere R, Saokar A,
Fernandez-del Castillo C, Brugge WR and Hahn PF: Cystic pancreatic
lesions: A simple imaging-based classification system for guiding
management. Radiographics. 25:1471–1484. 2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Yingzi S, Yanhong M, Liping W, Shiqin J,
et al: Analysis on ultrasonic diagnosis and misdiagnostic causes of
bile duct hamartoma in liver. J Med Imaging. 27:1509–1511.
2017.
|
7
|
Jain R, Fischer S, Serra S and Chetty R:
The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of
the pancreas, gastrointestinal tract, and liver. Appl
Immunohistochem Mol Morphol. 18:9–15. 2010.PubMed/NCBI View Article : Google Scholar
|
8
|
Chen L, Xu MY and Chen F: Bile duct
adenoma: A case report and literature review. World J Surg Oncol.
12(125)2014.PubMed/NCBI View Article : Google Scholar
|
9
|
Mu W, Su P and Ning S: Case report:
Incidentally discovered a rare cystic lesion of liver: Multicystic
biliary hamartoma. Pathol Oncol Res. 27(628323)2021.PubMed/NCBI View Article : Google Scholar
|
10
|
Jáquez-Quintana JO, Reyes-Cabello EA and
Bosques-Padilla FJ: Multiple biliary hamartomas, the ‘von Meyenburg
complexes’. Ann Hepatol. 16:812–813. 2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Venkatanarasimha N, Thomas R, Armstrong
EM, Shirley JF, Fox BM and Jackson SA: Imaging features of ductal
plate malformations in adults. Clin Radiol. 66:1086–1093.
2011.PubMed/NCBI View Article : Google Scholar
|
12
|
Veigel MC, Prescott-Focht J, Rodriguez MG,
Zinati R, Shao L, Moore CA and Lowe LH: Fibropolycystic liver
disease in children. Pediatr Radiol. 39:317–327, 420-421.
2009.PubMed/NCBI View Article : Google Scholar
|
13
|
Levy AD and Rohrmann CA Jr: Biliary cystic
disease. Curr Probl Diagn Radiol. 32:233–263. 2003.PubMed/NCBI View Article : Google Scholar
|
14
|
Lefere M, Thijs M, De Hertogh G, Verslype
C, Laleman W, Vanbeckevoort D, Van Steenbergen W and Claus F:
Caroli disease: Review of eight cases with emphasis on magnetic
resonance imaging features. Eur J Gastroenterol Hepatol.
23:578–585. 2011.PubMed/NCBI View Article : Google Scholar
|
15
|
Li J, Nie HF and Xiao R: Findings of
intrahepatic bile duct hamartoma imaging. Mod Diagn Treat.
24:2819–2820. 2013.
|
16
|
Zhong HB, Quan GM and Yuan T: Evaluation
of CT and MRI in the bile duct malformation. Radiol Pract.
27:1293–1297. 2012.
|
17
|
Aishima S, Tanaka Y, Kubo Y, Shirabe K,
Maehara Y and Oda Y: Bile duct adenoma and von Meyenburg
complex-like duct arising in hepatitis and cirrhosis: Pathogenesis
and histological characteristics. Pathol Int. 64:551–559.
2014.PubMed/NCBI View Article : Google Scholar
|
18
|
Ogura T, Kurisu Y, Miyano A and Higuchi K:
A huge rapidly-enlarging multicystic biliary hamartoma. Dig Liver
Dis. 50(723)2018.PubMed/NCBI View Article : Google Scholar
|
19
|
Nakanuma Y, Hoso M, Sanzen T and Sasaki M:
Microstructure and development of the normal and pathologic biliary
tract in humans, including blood supply. Microsc Res Tech.
38:552–570. 1997.PubMed/NCBI View Article : Google Scholar
|
20
|
Zheng RQ, Zhang B, Kudo M, Onda H and
Inoue T: Imaging findings of biliary hamartomas. World J
Gastroenterol. 11:6354–6359. 2005.PubMed/NCBI View Article : Google Scholar
|
21
|
Röcken C, Pross M, Brucks U, Ridwelski K
and Roessner A: Cholangiocarcinoma occurring in a liver with
multiple bile duct hamartomas (von Meyenburg complexes). Arch
Pathol Lab Med. 124:1704–1706. 2000.PubMed/NCBI View Article : Google Scholar
|
22
|
Holzinger F, Z'graggen K and Büchler MW:
Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage
cascade towards cholangiocarcinoma. Ann Oncol. 10 (Suppl
4):S122–S126. 1999.PubMed/NCBI
|
23
|
Nakanuma Y, Hoso M and Terada T: Clinical
and pathological features of cholangiocarcinoma. In: Okuda K, Tabor
E (eds). Liver Cancer. Churchill Livingstone, New York, pp279-290,
1997.
|
24
|
Martinoli C, Cittadini G Jr, Rollandi GA
and Conzi R: Case report: Imaging of bile duct hamartomas. Clin
Radiol. 45:203–205. 1992.PubMed/NCBI View Article : Google Scholar
|
25
|
Nagano Y, Matsuo K, Gorai K, Sugimori K,
Kunisaki C, Ike H, Tanaka K, Imada T and Shimada H: Bile duct
hamartomas (von Mayenburg complexes) mimicking liver metastases
from bile duct cancer: MRC findings. World J Gastroenterol.
12:1321–1323. 2006.PubMed/NCBI View Article : Google Scholar
|
26
|
Martin DR, Kalb B, Sarmiento JM, Heffron
TG, Coban I and Adsay NV: Giant and complicated variants of cystic
bile duct hamartomas of the liver: MRI findings and pathological
correlations. J Magn Reson Imaging. 31:903–911. 2010.PubMed/NCBI View Article : Google Scholar
|
27
|
Xu AM, Xian ZH, Zhang SH and Chen XF:
Intrahepatic cholangiocarcinoma arising in multiple bile duct
hamartomas: Report of two cases and review of the literature. Eur J
Gastroenterol Hepatol. 21:580–584. 2009.PubMed/NCBI View Article : Google Scholar
|
28
|
Mortelé B, Mortelé K, Seynaeve P,
Vandevelde D, Kunnen M and Ros PR: Hepatic bile duct hamartomas
(von Meyenburg complexes): MR and MR cholangiography findings. J
Comput Assist Tomogr. 26:438–443. 2002.PubMed/NCBI View Article : Google Scholar
|
29
|
Qing Q, Wenping W, Zhizhang X, et al:
Hemodynamics study of enhanced color flow images with ultrasonic
contrast agent levovist in hepatic focal lesions. Chin J Ultrason.
4:216–218. 2001.(In Chinese).
|
30
|
Zanrui S, Dingbiao M, Long Z, et al:
Clinical analysis of the blood supply of middle and advanced
primary liver cancer. Youjiang Med J. 4:471–472. 2008.(In
Chinese).
|
31
|
Lixue W: Characteristics and diagnostic
value of spiral CT dual phase enhanced scanning in hepatocellular
carcinoma. Youjiang Med J. 4:378–379. 2005.(In Chinese).
|
32
|
Jung EM, Clevert DA, Schreyer AG, Schmitt
S, Rennert J, Kubale R, Feuerbach S and Jung F: Evaluation of
quantitative contrast harmonic imaging to assess malignancy of
liver tumors: A prospective controlled two-center study. World J
Gastroenterol. 13:6356–6364. 2007.PubMed/NCBI View Article : Google Scholar
|
33
|
Jianhua Z, Feng H, Anhua L, et al: The
value of quantitative analysis of blood perfusion in the arterial
phase of contrast-enhanced ultrasound in the differential diagnosis
for focal nodular hyperplasia and hepatocellular carcinoma. Chin J
Ultrasound. 6:19–21. 2009.(In Chinese).
|
34
|
Shi QS, Xing LX, Jin LF, Wang H, Lv XH and
Du LF: Imaging findings of bile duct hamartomas: A case report and
literature review. Int J Clin Exp Med. 8:13145–13153.
2015.PubMed/NCBI
|